Immunogen, Inc. (IMGN) Tops Q2 EPS by 22c; Updates FY14 Revs Outlook
Tweet Send to a Friend
Immunogen, Inc. (NASDAQ: IMGN) reported Q2 EPS of $0.04, $0.22 better than the analyst estimate of ($0.18). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
